OQROGet OQRO Pro
Insider trade

Maia Biotechnology (MAIA)Director bought ~$100K

Stan Smith, Director at Maia Biotechnology, bought ~$100K of Maia Biotechnology shares.

~$100K
Approx. value · 75K sh @ $1.34
1.52M
Holds after · shares reported
Traded
Jun 1, 2026
Filed
Jun 2, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 27, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 27, 2026, the Board of Directors of MAIA Biotechnology, Inc. (the “Company”) approved one-time bonus payments of $312,610 to Vlad Vitoc, the Company’s Chief Executive Officer and $50,000 to Jeffrey Himmelreich, the Company’s Head of Finance, in consideration for their efforts in connection with the Company’s recent capital raise.”
  2. May 14, 2026Company filing · Form 8-K · Agreement endedEnded an important agreement
  3. Jun 1, 2026 · this disclosureInsider · 3 insiders in a week, 7th time since 2022Director purchased ~$100K of MAIA shares in the open market

What came next

  1. Jun 1, 2026Insider · 2 peopleInsiders: 2 purchases (~$104K)
  2. Aug 20, 2026InsiderDirector purchased ~$16K of MAIA shares in the open market
  3. Aug 24, 2026InsiderDirector purchased ~$2.4K of MAIA shares in the open market
  4. Aug 26, 2026InsiderDirector purchased ~$12K of MAIA shares in the open market
  5. Aug 27, 2026InsiderDirector purchased ~$109K of MAIA shares in the open market
  6. Aug 28, 2026InsiderDirector purchased ~$63K of MAIA shares in the open market
  7. Sep 10, 2026InsiderDirector purchased ~$50K of MAIA shares in the open market
  8. Sep 14, 2026InsiderCEO purchased ~$100K of MAIA shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Maia Biotechnology

For Maia Biotechnology, OQRO holds 7 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its MAIA page.

Other recent filings by Stan Smith, Director

The full history of Stan Smith, Director is on the profile page.

How this filing works

Other disclosures at Maia Biotechnology

Everything OQRO holds on this company is on its MAIA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data